COMBINEXT

Owners

Goods & Services

research services relating to treatments for infectious diseases; research services related to the development of vaccines; research and development of drug delivery platforms for use in the treatment of infectious diseases and disorders; research and development of compositions for use in targeted pharmaceutical therapies for the treatment of infectious diseases and disorders; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of infectious diseases; scientific and technological services, namely, research and development relating to compositions for use in the treatment of pulmonary viral infections; design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of compositions for use in the treatment of infectious diseases; consulting services relating to the design and development of targeted pharmaceutical therapies; Research services relating to the detection of pathogens; research and development of compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, scientific analysis in the field of research and development relating to compositions and preparations for use in the detection of pathogens; scientific and technological services, namely, research and development relating to compositions and preparations for use in the detection of pathogens; design and development of compositions for use in the detection of pathogens; consulting services relating to the design and development of compositions and preparations for use in the detection of pathogens